---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-028710"
form_type: "8-K"
ticker: "INSM"
cik: "0001104506"
company_name: "INSMED Inc"
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:27:36.508765+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "medium"
source: SEC EDGAR
---

# Insmed to host commercial webinar on June 4 to discuss market outlook for ARIKAYCE, brensocatib, treprostinil palmitil

## Summary
- Webinar at 8:00 a.m. ET on June 4, 2024, live via investor relations website.
- Focus on three programs: ARIKAYCE (amikacin liposome inhalation), brensocatib, and treprostinil palmitil inhalation powder.
- Slide presentation furnished as Exhibit 99.1 with title slide only; no specific financial data disclosed.

## SEC filing metadata
- accession: 0001140361-24-028710
- form_type: 8-K
- ticker: INSM
- cik: 0001104506
- company_name: INSMED Inc
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1104506/000114036124028710/0001140361-24-028710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1104506/000114036124028710/ef20030527_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-028710
- JSON: https://secwatch.observer/filing/0001140361-24-028710.json
- Plain text: https://secwatch.observer/filing/0001140361-24-028710.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.